| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $15.1B | $15.5B | $3.7B |
| Cost of Revenue | $6.3B | $6.5B | $6.8B |
| Gross Profit | $8.8B | $9.0B | $2.0B |
| R&D Expense | $0.4B | $0.4B | $0.4B |
| SG&A Expense | $6.1B | $6.3B | $6.1B |
| Operating Income | $2.4B | $1.8B | $2.5B |
| Net Income | $1.5B | $1.0B | $0.3B |
| EPS (Basic) | $0.77 | $0.54 | $0.17 |
| EPS (Diluted) | $0.76 | $0.54 | $0.17 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $27.1B | $25.6B | $27.9B |
| Current Assets | $5.7B | $5.5B | $6.1B |
| Cash & Equivalents | $1.1B | $1.1B | $1.4B |
| Total Liabilities | $16.3B | $15.9B | $16.6B |
| Current Liabilities | $5.9B | $5.7B | $5.5B |
| Stockholders' Equity | $10.8B | $9.7B | $11.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $2.2B | $1.8B | $3.2B |
| Investing Cash Flow | $-0.4B | $-0.4B | $-0.5B |
| Capital Expenditures | $0.5B | $0.4B | $0.5B |
| Financing Cash Flow | $-1.8B | $-1.6B | $-2.5B |